Purification of mouse primary myoblasts based on α7 integrin expression

被引:111
作者
Blanco-Bose, WE
Yao, CC
Kramer, RH
Blau, HM
机构
[1] Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA
[2] Univ Calif San Francisco, Sch Dent, Dept Stomatol, San Francisco, CA 94313 USA
关键词
myoblast purification; fluorescence-activated cell sorting; magnetic beads; primary muscle cells; alpha; 7; beta; 1; integrin;
D O I
10.1006/excr.2001.5191
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fundamental insights have come from the study of myogenesis. Primary myoblasts isolated directly from muscle tissue more closely approximate myogenesis than established cell lines. However, contamination of primary muscle cultures with nonmyogenic cells can complicate the results. To overcome this problem, we previously described a method for myoblast purification based on novel culture conditions (T. A. Rands and H. M. Blau, 1994, 6. Cell Biol. 125, 1275-1287). Here we report a refinement of this method that leads directly to an enriched population of mouse primary myoblasts, within significantly fewer population doublings. The method described here avoids using adhesion as a criterion for selection. This advance capitalizes on the ability of the antibody CA5.5 to recognize alpha7 integrin, a muscle-specific cell surface antigen. Enrichment of myoblasts to greater than 95% of the cell population can be achieved by a single round of dow cytometry or magnetic bead separation. This is the first description of a mouse myoblast purification method based on a cell-type-specific antigen. The ease of this procedure for isolating primary myoblasts should expand the opportunities for (1) using these cells in cell transplantation studies in animal models of human disease, (2) isolating and characterizing mutant myoblasts from transgenic animals, and (3) allowing in vitro studies of molecules that regulate muscle cell growth, differentiation, and neoplasia. (C) 2001 Academic Press.
引用
收藏
页码:212 / 220
页数:9
相关论文
共 45 条
[1]   SYSTEMIC DELIVERY OF RECOMBINANT PROTEINS BY GENETICALLY MODIFIED MYOBLASTS [J].
BARR, E ;
LEIDEN, JM .
SCIENCE, 1991, 254 (5037) :1507-1509
[2]   Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source [J].
Beauchamp, JR ;
Morgan, JE ;
Pagel, CN ;
Partridge, TA .
JOURNAL OF CELL BIOLOGY, 1999, 144 (06) :1113-1121
[3]  
BLANCOBOSE WE, 2001, IN PRESS DEV BIOL
[4]   MUSCLE-MEDIATED GENE-THERAPY [J].
BLAU, HM ;
SPRINGER, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1554-1556
[5]   PLASTICITY OF THE DIFFERENTIATED STATE [J].
BLAU, HM ;
PAVLATH, GK ;
HARDEMAN, EC ;
CHIU, CP ;
SILBERSTEIN, L ;
WEBSTER, SG ;
MILLER, SC ;
WEBSTER, C .
SCIENCE, 1985, 230 (4727) :758-766
[6]   THE MUSCLE SATELLITE CELL - A REVIEW [J].
CAMPION, DR .
INTERNATIONAL REVIEW OF CYTOLOGY-A SURVEY OF CELL BIOLOGY, 1984, 87 :225-251
[7]   Fusion competence of myoblasts rendered genetically null for N-cadherin in culture [J].
Charlton, CA ;
Mohler, WA ;
Radice, GL ;
Hynes, RO ;
Blau, HM .
JOURNAL OF CELL BIOLOGY, 1997, 138 (02) :331-336
[8]   GENE-THERAPY VIA PRIMARY MYOBLASTS - LONG-TERM EXPRESSION OF FACTOR-IX PROTEIN FOLLOWING TRANSPLANTATION INVIVO [J].
DAI, Y ;
ROMAN, M ;
NAVIAUX, RK ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :10892-10895
[9]   Improvement of mouse β-thalassemia upon erythropoietin delivery by encapsulated myoblasts [J].
Dalle, B ;
Payen, E ;
Regulier, E ;
Deglon, N ;
Rouyer-Fessard, P ;
Beuzard, Y ;
Aebischer, P .
GENE THERAPY, 1999, 6 (02) :157-161
[10]   SYSTEMIC DELIVERY OF HUMAN GROWTH-HORMONE BY INJECTION OF GENETICALLY ENGINEERED MYOBLASTS [J].
DHAWAN, J ;
PAN, LC ;
PAVLATH, GK ;
TRAVIS, MA ;
LANCTOT, AM ;
BLAU, HM .
SCIENCE, 1991, 254 (5037) :1509-1512